Insufficient scRNA-seq data for expression of IFNLR1 at single-cell level.
Insufficient scRNA-seq data for expression of IFNLR1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 595.86 | 328 / 328 | 96% | 6.56 | 170 / 178 |
thymus | 100% | 755.65 | 653 / 653 | 93% | 12.93 | 565 / 605 |
prostate | 96% | 688.79 | 235 / 245 | 93% | 6.96 | 468 / 502 |
lung | 94% | 444.52 | 544 / 578 | 88% | 7.39 | 1011 / 1155 |
adrenal gland | 99% | 434.19 | 255 / 258 | 82% | 5.39 | 188 / 230 |
kidney | 100% | 400.87 | 89 / 89 | 76% | 3.93 | 687 / 901 |
ovary | 80% | 188.91 | 144 / 180 | 88% | 6.83 | 377 / 430 |
liver | 100% | 885.08 | 226 / 226 | 66% | 4.70 | 268 / 406 |
stomach | 79% | 254.44 | 284 / 359 | 84% | 8.53 | 239 / 286 |
esophagus | 61% | 291.72 | 883 / 1445 | 95% | 10.95 | 173 / 183 |
intestine | 48% | 423.70 | 467 / 966 | 95% | 9.49 | 503 / 527 |
breast | 61% | 319.00 | 282 / 459 | 80% | 4.72 | 896 / 1118 |
skin | 72% | 837.50 | 1303 / 1809 | 60% | 6.03 | 282 / 472 |
bladder | 38% | 169.95 | 8 / 21 | 89% | 7.59 | 447 / 504 |
uterus | 35% | 87.55 | 60 / 170 | 81% | 6.83 | 374 / 459 |
brain | 57% | 316.84 | 1514 / 2642 | 54% | 2.66 | 384 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.37 | 29 / 29 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.71 | 1 / 1 |
spleen | 100% | 570.44 | 240 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 8.11 | 42 / 45 |
muscle | 93% | 333.19 | 743 / 803 | 0% | 0 | 0 / 0 |
heart | 78% | 236.78 | 674 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 41% | 258.24 | 385 / 929 | 0% | 0 | 0 / 0 |
adipose | 21% | 51.24 | 256 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 13% | 0.33 | 10 / 80 |
blood vessel | 5% | 11.51 | 71 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051607 | Biological process | defense response to virus |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0098586 | Biological process | cellular response to virus |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0050691 | Biological process | regulation of defense response to virus by host |
GO_0038196 | Biological process | type III interferon-mediated signaling pathway |
GO_0002385 | Biological process | mucosal immune response |
GO_1901857 | Biological process | positive regulation of cellular respiration |
GO_0034342 | Biological process | response to type III interferon |
GO_0032002 | Cellular component | interleukin-28 receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0004896 | Molecular function | cytokine receptor activity |
Gene name | IFNLR1 |
Protein name | Interferon lambda receptor 1 (IFN-lambda receptor 1) (IFN-lambda-R1) (Cytokine receptor class-II member 12) (Cytokine receptor family 2 member 12) (CRF2-12) (Interleukin-28 receptor subunit alpha) (IL-28 receptor subunit alpha) (IL-28R-alpha) (IL-28RA) (Likely interleukin or cytokine receptor 2) (LICR2) Interferon lambda receptor 1 |
Synonyms | IL28RA LICR2 |
Description | FUNCTION: The IFNLR1/IL10RB dimer is a receptor for the cytokine ligands IFNL2 and IFNL3 and mediates their antiviral activity. The ligand/receptor complex stimulate the activation of the JAK/STAT signaling pathway leading to the expression of IFN-stimulated genes (ISG), which contribute to the antiviral state. Determines the cell type specificity of the lambda interferon action. Shows a more restricted pattern of expression in the epithelial tissues thereby limiting responses to lambda interferons primarily to epithelial cells of the respiratory, gastrointestinal, and reproductive tracts. Seems not to be essential for early virus-activated host defense in vaginal infection, but plays an important role in Toll-like receptor (TLR)-induced antiviral defense. Plays a significant role in the antiviral immune defense in the intestinal epithelium. . |
Accessions | ENST00000374421.7 [Q8IU57-2] ENST00000374419.1 ENST00000327575.6 [Q8IU57-4] Q8IU57 Q5VTX9 ENST00000374418.3 [Q8IU57-3] ENST00000327535.6 [Q8IU57-1] |